Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sexual Transmission of Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT05141422
What this trial is testing

A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers

Who this might be right for
Human Immunodeficiency Virus Infection
Jiangsu HengRui Medicine Co., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT00001122
What this trial is testing

An Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 74
Not applicableUnknownNCT03747770
What this trial is testing

Effectiveness of Single Dose or Two Doses of Bivalent HPV Vaccine in Thailand

Who this might be right for
Healthy
International Vaccine Institute 18,000
Early research (Phase 1)Study completedNCT00002261
What this trial is testing

A Comparative Phase I Clinical Study of HIVAC-1e and Smallpox (Vaccinia) Vaccines in Previously (Vaccinia) Vaccinated and Unvaccinated Volunteers

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Post-approval studies (Phase 4)Study completedNCT01059422
What this trial is testing

Raltegravir + Lamivudine/Abacavir in HIV/Tuberculosis Co-Infected Patients

Who this might be right for
HIV InfectionsTuberculosis
Central Institute of Epidemiology, Moscow, Russia 10
Large-scale testing (Phase 3)Study completedNCT00324103
What this trial is testing

Structured Treatment Interruptions in Chronic HIV Infection

Who this might be right for
HIV Infection
Istituto Superiore di Sanità 600
Large-scale testing (Phase 3)Study completedNCT00943722
What this trial is testing

V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolescents and Adolescents (V503-002)

Who this might be right for
Cervical CancersVulvar CancerVaginal Cancer+3 more
Merck Sharp & Dohme LLC 3,074
Not applicableStudy completedNCT01103856
What this trial is testing

Test of an Intervention to Improve HIV Care

Who this might be right for
HIV Infection
Baylor College of Medicine 460
Not applicableUnknownNCT04779996
What this trial is testing

Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment

Who this might be right for
Covid19CancerHIV Infections
Auxilio Mutuo Cancer Center 250
Early research (Phase 1)Looking for participantsNCT06796686
What this trial is testing

Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health

Who this might be right for
HIV
National Institute of Allergy and Infectious Diseases (NIAID) 42
Early research (Phase 1)WithdrawnNCT00000856
What this trial is testing

A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.

Who this might be right for
EncephalopathyHIV InfectionsRadiculitis
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT04034862
What this trial is testing

Impact of DOlutegravir+Lamivudine Simplification on HIV-1 Reservoirs

Who this might be right for
HIV Infections
University of Liege 36
Post-approval studies (Phase 4)Study completedNCT00447070
What this trial is testing

Effect of Atazanavir on Endothelial Function in HIV-Infected Patients

Who this might be right for
HIV InfectionsDyslipidemia
Foundation for Cardiovascular Research, Zurich 50
Post-approval studies (Phase 4)UnknownNCT00247494
What this trial is testing

Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients

Who this might be right for
HIV InfectionAtherosclerosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 90
Not applicableEnrolling By InvitationNCT06488846
What this trial is testing

Innovative Administration of Long-Acting Injectables for HIV Treatment Enhancement at Home

Who this might be right for
HIV Infections
University of California, San Francisco 1,000
Not applicableStudy completedNCT00007488
What this trial is testing

HIV in Specific Parts of the Body of Patients Who Are Changing or Starting Potent Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 164
Not applicableStudy completedNCT02043769
What this trial is testing

Pediatric Enhanced Surveillance Study

Who this might be right for
Human Immunodeficiency Virus (HIV)Acquired Immune Deficiency Syndrome (AIDS)
Columbia University 396
Large-scale testing (Phase 3)Study completedNCT00043966
What this trial is testing

Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects

Who this might be right for
HIV Infections
Abbott 200
Large-scale testing (Phase 3)Study completedNCT00001016
What this trial is testing

A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved Therapies

Who this might be right for
Pneumonia, Pneumocystis CariniiHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Early research (Phase 1)Study completedNCT03984838
What this trial is testing

Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent

Who this might be right for
HIV Infections
ViiV Healthcare 16
Next Page